Copd Exacerbation

WASHINGTON — Patients with COPD who also have depression and/or anxiety may not be receiving the treatment they need due to their respiratory disease, according to a presentation at the American Thoracic Society International Conference.

WASHINGTON — Compared with other hypnotics, a class of insomnia hypnotics did not raise the risk for death or inpatient COPD exacerbations, according to research presented at the American Thoracic Society International Conference.

A pragmatic health system-level intervention improved quality of life for patients discharged after COPD exacerbation but failed to reduce 180-day readmission or mortality, researchers reported.

Among patients with COPD, mortality was higher after hospital admission with pneumonia compared with admission with COPD exacerbation, according to results published in the European Respiratory Journal.

History of exacerbations, as well as severity of dyspnea, may predict future exacerbations in patients with COPD, according to results of an observational study published in Respiratory Medicine.

In patients hospitalized with COPD exacerbations, those who received usual care plus an active strategy for diagnosing pulmonary embolism did not have improved outcomes compared with those who received usual care only.

Researchers reported nine air pollutants and meteorological factors are associated with an increase in the incidence of COPD exacerbations, for a lag time of up to 10 days.

Therapeutic immunomodulation with a sublingual mucosal bacterial vaccine in adults with COPD reduced the number and length of exacerbations and antibiotic use, researchers reported at the European Respiratory Society International Congress.

Common genetic variants do not appear to play an important role in predicting acute exacerbations of COPD or treatment response to triple therapy, researchers reported in Respiratory Medicine.

A new study found that marijuana users who were hospitalized for a chronic obstructive pulmonary disease exacerbation had lower odds of in-hospital mortality compared with nonusers.